Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinica...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., Sept. 24, 2021 /PRNewswire-AsiaNet/ -- - Pivotal Phase 3 trial achieved all primary endpoints, demonstrating non-inferiority to a leading U.S.-licensed quadrivalent influenza vaccine- NanoFlu(TM) vaccine candidate induced significantly enhanced cell-mediated immune responses- N...
Authors: LATEST ASIANET NEWS RELEASES